FHA
ZSAN

Flagship Harbor Advisors’s Zosano Pharma Corporation ZSAN Stock Holding History

Flagship Harbor Advisors’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3
Closed – – 1936
2020
Q3 		$0 Hold
3
– – ﹤0.01% 2231
2020
Q2 		$0 Hold
3
– – ﹤0.01% 2206
2020
Q1 		$0 Hold
3
– – ﹤0.01% 2022
2019
Q4 		$0 Hold
3
– – ﹤0.01% 1985
2019
Q3 		$0 Hold
3
– – ﹤0.01% 2016
2019
Q2 		$0 Hold
3
– – ﹤0.01% 2020
2019
Q1 		$0 Hold
3
– – ﹤0.01% 1994
2018
Q4 		$0 Hold
3
– – ﹤0.01% 2169
2018
Q3 		$0 Hold
3
– – ﹤0.01% 2161
2018
Q2 		$0 Buy
+3
New +$452 ﹤0.01% 2093

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Flagship Harbor Advisors's ZSAN Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Zosano Pharma Corporation (ZSAN) in Q4 2020, closing a stake of 3 shares.

Flagship Harbor Advisors first reported a position in ZSAN in Q2 2018 and held it in 10 quarters. The position peaked at $0 in Q3 2020. 34 funds tracked by Wall St. Rank hold ZSAN as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Zosano Pharma Corporation position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 3 Zosano Pharma Corporation shares in Q4 2020.
  • Flagship Harbor Advisors first reported a position in Zosano Pharma Corporation in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Zosano Pharma Corporation position peaked at $0 in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.